首页> 外文期刊>Expert opinion on therapeutic targets >Galanin receptors as a potential target for neurological disease
【24h】

Galanin receptors as a potential target for neurological disease

机译:甘丙肽受体作为神经系统疾病的潜在靶标

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Galanin is a 29/30 amino acid long neuropeptide that is widely expressed in the brains of many mammals. Galanin exerts its biological activities through three different G protein-coupled receptors, GalR1, GalR2 and GalR3. The widespread distribution of galanin and its receptors in the CNS and the various physiological and pharmacological effects of galanin make the galanin receptors attractive drug targets.Areas covered: This review provides an overview of the role of galanin and its receptors in the CNS, the involvement of the galaninergic system in various neurological diseases and the development of new galanin receptor-specific ligands.Expert opinion: Recent advances and novel approaches in migrating the directions of subtype-selective ligand development and chemical modifications of the peptide backbone highlight the importance of the galanin neurochemical system as a potential target for drug development.
机译:简介:甘丙肽是一种长29/30个氨基酸的神经肽,在许多哺乳动物的大脑中广泛表达。甘丙肽通过三种不同的G蛋白偶联受体GalR1,GalR2和GalR3发挥其生物学活性。甘丙肽及其受体在中枢神经系统中的广泛分布以及甘丙肽的各种生理和药理作用使甘丙肽受体成为具有吸引力的药物靶标。研究领域:本综述概述了甘丙肽及其受体在中枢神经系统中的作用,涉及galaninergic系统在各种神经系统疾病中的作用以及新的甘丙肽受体特异性配体的发展。专家意见:迁移亚型选择性配体发展方向和肽骨架化学修饰的最新进展和新方法凸显了甘丙肽的重要性神经化学系统作为药物开发的潜在目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号